Turner LD - Search Results

1

Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay.

Shirey RJ, Hart JR, Sridharan B, Novick SJ, Turner LD, Zhou B, Nielsen AL, Eubanks LM, Ueno L, Hixon MS, Lairson LL, Spicer TP, Scampavia LD, Griffin PR, Vogt PK, Janda KD. Shirey RJ, et al. Among authors: turner ld. Bioorg Med Chem. 2021 Jul 15;42:116246. doi: 10.1016/j.bmc.2021.116246. Epub 2021 Jun 6. Bioorg Med Chem. 2021. PMID: 34130216 Free PMC article.

2

Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A.

Lin L, Olson ME, Sugane T, Turner LD, Tararina MA, Nielsen AL, Kurbanov EK, Pellett S, Johnson EA, Cohen SM, Allen KN, Janda KD. Lin L, et al. Among authors: turner ld. J Med Chem. 2020 Oct 8;63(19):11100-11120. doi: 10.1021/acs.jmedchem.0c01006. Epub 2020 Sep 18. J Med Chem. 2020. PMID: 32886509 Free PMC article.

3

Identification of 3-hydroxy-1,2-dimethylpyridine-4(1H)-thione as a metal-binding motif for the inhibition of botulinum neurotoxin A.

Lin L, Turner LD, Šilhár P, Pellett S, Johnson EA, Janda KD. Lin L, et al. Among authors: turner ld. RSC Med Chem. 2020 Nov 12;12(1):137-143. doi: 10.1039/d0md00320d. eCollection 2021 Jan 1. RSC Med Chem. 2020. PMID: 34046606 Free PMC article.

4

COVALENT INHIBITION OF BOTULINUM NEUROTOXIN A - EXPLORATION OF WARHEAD REACTIVITY AND FUNCTION USING A BIFUNCTIONAL APPROACH.

Turner LD, Nielsen AL, Lin L, Pellett S, Sugane T, Olson ME, Janda KD. Turner LD, et al. Toxicon. 2021 Jan;190(Suupl 1):S72-S73. Epub 2021 Jan 16. Toxicon. 2021. PMID: 34103769 Free PMC article.

5

Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach.

Turner LD, Nielsen AL, Lin L, Pellett S, Sugane T, Olson ME, Johnson EA, Janda KD. Turner LD, et al. RSC Med Chem. 2021 May 19;12(6):960-969. doi: 10.1039/d1md00089f. eCollection 2021 Jun 23. RSC Med Chem. 2021. PMID: 34223161 Free PMC article.

6

Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.

Shirey RJ, Turner LD, Lairson LL, Janda KD. Shirey RJ, et al. Among authors: turner ld. Bioorg Med Chem Lett. 2021 Oct 1;49:128293. doi: 10.1016/j.bmcl.2021.128293. Epub 2021 Jul 28. Bioorg Med Chem Lett. 2021. PMID: 34332037

7

Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A Protease.

Turner LD, Nielsen AL, Lin L, Campedelli AJ, Silvaggi NR, Chen JS, Wakefield AE, Allen KN, Janda KD. Turner LD, et al. ACS Med Chem Lett. 2021 Jul 28;12(8):1318-1324. doi: 10.1021/acsmedchemlett.1c00325. eCollection 2021 Aug 12. ACS Med Chem Lett. 2021. PMID: 34413962 Free PMC article.

8

From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.

Turner LD, Trinh CH, Hubball RA, Orritt KM, Lin CC, Burns JE, Knowles MA, Fishwick CWG. Turner LD, et al. J Med Chem. 2022 Jan 27;65(2):1481-1504. doi: 10.1021/acs.jmedchem.1c01163. Epub 2021 Nov 15. J Med Chem. 2022. PMID: 34780700 Free article.

9

Identification of Slow-Binding Inhibitors of the BoNT/A Protease.

Patel EN, Turner LD, Hixon MS, Janda KD. Patel EN, et al. Among authors: turner ld. ACS Med Chem Lett. 2022 Mar 8;13(4):742-747. doi: 10.1021/acsmedchemlett.2c00028. eCollection 2022 Apr 14. ACS Med Chem Lett. 2022. PMID: 35450355 Free PMC article.

10

Transformation of a Metal Chelate into a "Catch and Anchor" Inhibitor of Botulinum A Protease.

Lin L, Patel EN, Nielsen AL, Turner LD, Tepp WH, Nguyen K, Pellett S, Janda K. Lin L, et al. Among authors: turner ld. Int J Mol Sci. 2023 Feb 21;24(5):4303. doi: 10.3390/ijms24054303. Int J Mol Sci. 2023. PMID: 36901734 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters